Merck KGaA (MKKGY)
OTCMKTS
· Delayed Price · Currency is USD
27.98
+0.18 (0.65%)
At close: Dec 5, 2025
Merck KGaA Employees
Merck KGaA had 59,020 employees as of December 31, 2024. The number of employees decreased by 3,888 or -6.18% compared to the previous year.
Employees
59,020
Change (1Y)
-3,888
Growth (1Y)
-6.18%
Revenue / Employee
$400,301
Profits / Employee
$55,629
Market Cap
61.02B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 59,020 | -3,888 | -6.18% |
| Dec 31, 2023 | 62,908 | -1,324 | -2.06% |
| Dec 31, 2022 | 64,232 | 3,898 | 6.46% |
| Dec 31, 2021 | 60,334 | 2,207 | 3.80% |
| Dec 31, 2020 | 58,127 | 1,056 | 1.85% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| CytoDyn | 13 |
| American Oncology Network | 1,914 |
| Northwest Biotherapeutics | 25 |
| Silence Therapeutics | 116 |
| Zomedica | 152 |
Merck KGaA News
- 1 day ago - Halozyme Granted Injunction Against Merck & Co. in Germany in Keytruda Patent Case - WSJ
- 1 day ago - Dr. Rasha Kelej of Merck Foundation Meets Nigeria First Lady at the Merck Foundation Africa Asia Luminary 2025 - Business Upturn
- 10 days ago - Merck Foundation Observes the ‘Day for Elimination of Violence Against Women 2025’ Through Their More Than a Mother Campaign and Educating Linda Program - Business Upturn
- 14 days ago - Equinix Hosts Merck KGaA's HPC at its Data Center in Germany - Nasdaq
- 15 days ago - Valo Health Partners with Merck KGaA in $3B AI Drug Discovery Deal - GuruFocus
- 15 days ago - Merck KGaA inks $3B deal to discover Parkinson’s drugs using AI - Seeking Alpha
- 16 days ago - Merck KGaA to draw on Valo's drug discovery AI in potential $3 billion deal - Reuters
- 16 days ago - Valo Health Announces Collaboration with Merck KGaA, Darmstadt, Germany to Discover and Develop Novel Treatments for Parkinson's Disease and Related Disorders - Business Wire